To determine whether latent sensitivity to respiratory syncytial virus antigen(s) occurs after infection, 27 infants with acute bronchiolitis were studied and compared with 15 hospital controls. Blood was collected for whole blood challenge, and histamine release was measured by a high performance liquid chromatography technique with fluorometric detection. There was a significantly greater histamine release to respiratory syncytial virus antigen(s) in those with bronchiolitis than in controls, expressed either in amount (median 154 nmol/l compared with 104 nmol/l) or percentage release (median 20% compared with 3%). There was a significant difference between index and control groups in terms of individual histamine responses. These findings strongly suggest that infants develop latent sensitivity to respiratory syncytial virus antigen(s) during the course of acute bronchiolitis.
Abstract
To determine whether latent sensitivity to respiratory syncytial virus antigen(s) occurs after infection, 27 infants with acute bronchiolitis were studied and compared with 15 hospital controls. Blood was collected for whole blood challenge, and histamine release was measured by a high performance liquid chromatography technique with fluorometric detection. There was a significantly greater histamine release to respiratory syncytial virus antigen(s) in those with bronchiolitis than in controls, expressed either in amount (median 154 nmol/l compared with 104 nmol/l) or percentage release (median 20% compared with 3%). There was a significant difference between index and control groups in terms of individual histamine responses. These findings strongly suggest that infants develop latent sensitivity to respiratory syncytial virus antigen(s) during the course of acute bronchiolitis.
Serial lung function tests were performed in 15 infants. All infants had abnormalities of lung function at some stage, but the small numbers of subjects precluded comparison between 'sensitised' and 'non-sensitised' infants. Further study is indicated to define the relation of latent sensitisation and subsequent bronchial hyper-responsiveness after respiratory syncytial virus infection in infants.
syncytial virus antigen(s) occurs during the course of attacks of acute bronchiolitis in infancy, and whether there may be a relationship between latent sensitivity and lung function (including the responsiveness of airways to histamine) after apparent recovery from the acute illness.
Patients and methods

LATENT SENSITIVITY
Patients Twenty seven infants with bronchiolitis (mean age 17 weeks, range were studied during the 1987/8 winter outbreak of respiratory syncytial virus infection. Fifteen infants (mean age 13 weeks, range , in hospital for nonrespiratory illnesses, were studied as a control group. Six had been born after the end of the 1986/7 winter outbreak of respiratory syncytial virus infection and were studied before the onset of the 1987/8 outbreak.
The clinical details and course of the illness were carefully recorded for each index case. Nasopharyngeal aspirates were obtained so that viruses could be identified by indirect immunofluorescence and tissue culture. During venepuncture for routine clinical investigations an additional 2 ml venous blood was obtained for 'challenge' studies. Department Infections with respiratory syncytial virus occur in epidemics every winter in the United Kingdom, and are the main cause of acute bronchiolitis in infancy.' The virus is also associated with the sudden infant death syndrome (SIDS), which has a peak age range (2 to 6 months) similar to that of acute bronchiolitis.2 Allergic sensitisation of the airways as a result of infection with respiratory syncytial virus has been postulated as an explanation for increased respiratory morbidity after apparent recovery from acute bronchiolitis,3 4 and as a mechanism of death in some cases of SIDS.s 6 The hypothesis of modified anaphylaxis as a cause of SIDS presupposes that mast cells and basophils are sensitised in some way by IgE and then release chemical mediators on subsequent exposure to specific allergens. Latent anaphylactic sensitivity of infants to allergens has been shown experimentally by assay of histamine release from blood on exposure to specific allergens-for example cows' milk proteins. 7 The main aim of the present study was Ethical approval This study was approved by the Leicestershire Health Authority ethics committee. Informed consent was obtained from the parents of all infants after a thorough explanation of the nature of the study, and the tests and procedures to be undertaken.
Results
LATENT SENSITISATION
Comparability of the groups There were significantly more boys in the control group than in the index group; no other differences were found (table 1).
Identification of viruses
Respiratory syncytial virus was identified from nasopharyngeal aspirates in 16 of the 27 infants in the index group. There were no significant differences in the clinical presentation or course of these infants when compared with those in whom respiratory syncytial virus was not identified (table 2) .
Histamine release When index and control groups are considered separately, neither age nor interval between onset of illness and blood sample had a significant effect on either total histamine release or on histamine release in response to the various challenges undertaken.
Within the bronchiolitis group no differences were observed between those infants who did and those who did not have respiratory syncytial virus isolated for any of the variables measured. Family history of atopic disorder 17 5 *p<O05. At the second test, eight months after the original illness, eight infants showed functional improvement. One remained hyperinflated and three had raised airways resistance. The median VmaxFRC had increased from 18 to 27% predicted. Nine infants fulfilled the criteria for histamine challenge (mean (SD) PD30=0-62 (0-47) g/l). Severity of lung dysfunction in terms of overall mechanical properties was not associated with latent sensitisation during the acute illness, clinical severity of the acute bronchiolitis, duration of hospital stay, or the frequency and severity of symptoms that developed after discharge from hospital.
Paired data on responsiveness to inhaled histamine challenge was obtained for only four infants-all of whom were 'sensitised' to respiratory syncytial virus allergen(s). Paucity of data on 'non-sensitised' or uninformative cases does not permit comparison of 'sensitised' and 'non-sensitised' infants.
Discussion LATENT SENSITISATION
The basophil histamine release system is an established laboratory model of the anaphylactic reaction." Assays can be carried out either in whole blood or in a preparation of washed white cells. Histamine release from whole blood was chosen for this study, as this system is more physiological and retains full viability and reactivity of the basophils. Basophil histamine release detects sensitisation of basophil by IgE antibodies specific to the allergen-in this case respiratory syncytial virus-and may be more sensitive than estimation of allergen specific circulating IgE, particularly if total IgE concentrations are low.
IgE mediated histamine release from basophils or whole blood may be influenced by many factors including age, allergic disease, and viral infection. The index and control groups were comparable with respect to age, allergic disease background, and total serum IgE and IgG4 concentrations. Interference from non-immune mechanisms of histamine release was minimised by using isotonic solutions when preparing the blood, and avoiding mechanical trauma to the basophils. None of the subjects had been given drugs that are known to release histamine. As we were interested in sensitisation to viral antigen(s), the time interval between infection and sampling was clearly important. There was, however, no correlation between the interval between the onset of illness and the time of taking the blood samples (median six days), and the total basophil histamine concentration or the release of histamine in response to the various challenges.
Histamine release is generally expressed as a percentage of the total histamine concentration. This is not an entirely satisfactory way to express the results of challenges in infants with low total histamine concentrations as a difference in histamine release, expressed in nmol/l, that is less than that caused by the variability of the method could produce a misleadingly large percentage histamine release. For this reason we have presented both actual histamine concentrations and the percentage of histamine released.
Ethical constraints meant that venous blood samples were often taken before virological identification was complete. Respiratory syncytial virus was identified in 16 of the 27 infants with clinical bronchiolitis (59%), which compares favourably with a reported sensitivity of immunofluorescence under ideal circumstances of 70%.12 The subgroup of infants in whom the virus was identified tended to have more severe acute illnesses, although individual indices of severity were not significant (table 2) . Severity of illness is related to viral shedding in the respiratory tract and may account for the ease with which viruses could be identified.'3 Infants in hospital with non-respiratory disorders were selected as the control group, the preponderance of boys being partly explained by the fact that several had congenital hypertrophic pyloric stenosis.
There is a wide range in whole blood histamine concentration in infancy and that reported in this study of 107-1251 nmol/l (equivalent to 22-230 ng/ml) is higher than the range reported previously by McLaughlan and Coombs of 12-128 ng/ml.7 The histamine release to antiIgE was variable, and nine subjects (33%) showed <15% response to this challenge. Limitations in the size of the blood samples meant that challenges were made at only one concentration of anti-IgE, which may not have produced optimal release of histamine in each case. Our results are comparable with those of McLaughlan and Coombs, however, who reported that only 17% of the group showed no response to IgE antibody. 7 Our results suggest that latent sensitivity to respiratory syncytial virus antigen(s) occurs during the course of infection with respiratory syncytial virus (tables 3 and 5). Both the within group and between group comparisons suggest that challenge with respiratory syncytial virus antigen has a significant effect on release of histamine from whole blood. Among individual infants 13 with bronchiolitis and four controls were considered respiratory syncytial virus 'responders' from their percentage release of histamine (>15%). The figure indicating a significant percentage release of histamine, however, varies among published reports, McLaughlan chose 9% on the basis of an adult control population7; others have used 30% or >50% of that produced by the optimal IgE concentration.'4 1' We cannot explain the variations in responsiveness among infants in the bronchiolitis group, and have no information about whether interferon production or respiratory syncytial virus subtype influenced the results. '5 The uncritical assumption that our results indicate allergic sensitisation to respiratory syncytial virus antigen(s) is not warranted. We did not include a 'control' virus challenge in our study design so that a non-specific viral effect cannot be excluded, although any such effect would have affected index and control groups of infants similarly. Perhaps of greater relevance is the finding of positive responses to challenge with culture medium containing no respiratory 
